Trinity Biotech PLC Amends Constitution and Credit Agreement

Trinity Biotech PLC, a foreign private issuer, filed a Form 6-K with the SEC for October 2025. The filing reports that at the company's Annual General Meeting held on September 30, 2025, shareholders approved resolutions resulting in amendments to the company's Constitution. Additionally, the company and certain subsidiaries amended the credit agreement governing their term loan facility with Perceptive Credit Holdings III, L.P. The amended Constitution and the amendment to the credit agreement are included as exhibits in the filing. The amended Constitution outlines the company's objectives, including the acquisition and management of shares, real and personal property, and the execution of various business activities. The credit agreement amendment details changes to the terms of the loan facility. This filing is incorporated by reference into the company's Registration Statements on Form S-8.